Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-9-12
|
pubmed:abstractText |
Verapamil poisoning is known to produce hyperglycemia and metabolic acidosis in humans. The purpose of this study was to elucidate mechanisms of verapamil-induced hyperglycemia in awake dogs. Mongrel canines were chronically instrumented to permit studies in the conscious state. In six healthy dogs, steady-state glucose infusion requirement after 1 hr of insulin infusion at 1000 mU/min was 19 +/- 1 mg/kg/min. In six separate dogs, verapamil toxicity was induced via verapamil infusion in the portal vein; during verapamil toxicity, the glucose infusion requirement with an insulin infusion rate of 1000 mU/min was significantly decreased (3 +/- 1 mg/kg/min; p < 0.05, unpaired t test). Eleven other verapamil-toxic dogs were also treated with either saline (n = 6, 3.0 ml/kg/hr) or glucagon (n = 5, 10 microg/kg/min). Insulin concentrations were not changed vs basal concentrations in either group. Catecholamine concentrations increased at least 15-fold in all groups (from 458 +/- 169 to 6973 +/- 480 pg/L in the saline-treated group). Glucose concentrations increased in saline-treated animals from 3.7 +/- 0.3 to 11.2 +/- 1.0 micromol/L, and with glucagon treatment, increased from 3.3 +/- 0.3 to 16.1 +/- 1.6 micromol/L (p < 0.05 vs saline, ANOVA). Verapamil poisoning appears to produce hyperglycemia by inducing systemic insulin resistance, blocking insulin release, together with an intact stress hormone response and glucogenic capacity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium Chloride,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0041-008X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
357-62
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9266809-Animals,
pubmed-meshheading:9266809-Diabetes Mellitus, Experimental,
pubmed-meshheading:9266809-Dogs,
pubmed-meshheading:9266809-Female,
pubmed-meshheading:9266809-Glucagon,
pubmed-meshheading:9266809-Glucose,
pubmed-meshheading:9266809-Hyperglycemia,
pubmed-meshheading:9266809-Infusions, Intravenous,
pubmed-meshheading:9266809-Insulin,
pubmed-meshheading:9266809-Insulin Antagonists,
pubmed-meshheading:9266809-Male,
pubmed-meshheading:9266809-Sodium Chloride,
pubmed-meshheading:9266809-Verapamil
|
pubmed:year |
1997
|
pubmed:articleTitle |
The diabetogenic effects of acute verapamil poisoning.
|
pubmed:affiliation |
Department of Emergency Medicine, Carolinas Medical Center, Charlotte, North Carolina 28232, USA.
|
pubmed:publicationType |
Journal Article
|